These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21669281)

  • 1. Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice.
    Yang JL; Chen JS; Yang YF; Chen JC; Lin CH; Chang RS; Tsao PJ; Chen FP; Chern CM; Tsai TH; Chiu JH
    Brain Behav Immun; 2011 Oct; 25(7):1452-9. PubMed ID: 21669281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
    Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
    Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: microarray analysis.
    Yeo S; Choi YG; Hong YM; Lim S
    Gene; 2013 Feb; 515(2):329-38. PubMed ID: 23235115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease.
    Shimoji M; Zhang L; Mandir AS; Dawson VL; Dawson TM
    Brain Res Mol Brain Res; 2005 Mar; 134(1):103-8. PubMed ID: 15790534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice.
    Jung HW; Son HY; Jin GZ; Park YK
    Cell Biochem Funct; 2010 Apr; 28(3):217-23. PubMed ID: 20186864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia.
    Fisher BE; Petzinger GM; Nixon K; Hogg E; Bremmer S; Meshul CK; Jakowec MW
    J Neurosci Res; 2004 Aug; 77(3):378-90. PubMed ID: 15248294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model.
    Kang JM; Park HJ; Choi YG; Choe IH; Park JH; Kim YS; Lim S
    Brain Res; 2007 Feb; 1131(1):211-9. PubMed ID: 17173870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S
    Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
    Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.
    Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M
    Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
    Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
    J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta).
    Shughrue PJ
    Exp Neurol; 2004 Dec; 190(2):468-77. PubMed ID: 15530885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
    Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD
    Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.
    Shaw VE; Keay KA; Ashkan K; Benabid AL; Mitrofanis J
    Parkinsonism Relat Disord; 2010 Jun; 16(5):338-44. PubMed ID: 20227323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.